The Pharmafocus Interview: Jan Lundberg AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
Genetics revolution set for NHS The Government has unveiled a comprehensive plan to integrate advances in genetics within the NHS, including the increase of genetic testing...(more)
Pfizer cool on Prilosec OTC launch Pfizer has criticised the US approval of an over-the-counter formulation of AstraZeneca's heartburn drug Prilosec, saying it will only serve to confuse the public...(more)
Reform continues as doctors accept contract Doctors across the UK have overwhelmingly voted in favour of the new GP contract, ending months of uncertainty about the reform of general practice...(more)
Final battle for future of US healthcare draws near The future of the US healthcare system and how patients pay for their medicines will be decided in the coming weeks as a long-running battle for change reaches its climax...(more)
Pharma invests millions in UK sites Several major pharma companies have shown their long-term commitment to the UK by investing millions of pounds in new and expanded facilities...(more)
GSK resumes talks on pay GlaxoSmithKline has resumed talks with some of its largest shareholders to try and reach an agreement on its controversial executive pay policies...(more)
Faster market access for generics in US Laws governing the entry of generic drugs on the US market are to be streamlined in an effort to cut prescription drug costs for patients and health insurance schemes...(more)
Trial failure puts spotlight on Celltech pipeline Celltech has been forced to abandon trials of a late-stage drug after the FDA indicated it was unlikely to demonstrate efficacy in treating non-small cell lung cancer...(more)
CROs continue to extend global reach Contract research organisations from Europe and the US are continuing to expand their operations in order to meet the pharmaceutical industry demand for globalised services...(more)
Health authorities blocking change, say PCTs Strategic health authorities are too far removed from PCTs to help them innovate as they work on their plans for the future, according to the NHS Alliance...(more)
